Northrop Grumman’s B-21 Raider Continues Its Flight Test Campaign
The B-21 Raider continues its flight test campaign at Edwards Air Force Base, California. (Photo Credit: Northrop Grumman)
EDWARDS AIR FORCE BASE, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- (PHOTO RELEASE) Northrop Grumman Corporation’s (NYSE: NOC) B-21 Raider continues its flight test campaign at Edwards Air Force Base, California, led by a Combined Test Force (CTF) comprised of Northrop Grumman and U.S. Air Force personnel. CTF test pilots indicate the jet is performing as expected with the aircraft flying like the simulator, reflecting the precision of the digital environment on B-21.
For more information about the B-21, please click here.
Contact: Christine Denton
321-272-4907
christine.denton@ngc.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/edb65257-b2a3-4410-91ad-d15016d55457
![](https://ml.globenewswire.com/media/MmVhNjRkMTYtZjcyZS00ZTg2LWE5MmItZTFhMWQ3M2Y1MjE2LTEwMjI0ODE=/tiny/Northrop-Grumman-Corporation.png)
Northrop Grumman’s B-21 Raider Continues Its Flight Test Campaign
![](https://ml.globenewswire.com/media/edb65257-b2a3-4410-91ad-d15016d55457/medium/northrop-grummans-b-21-raider-continues-its-flight-test-camp.jpg)
The B-21 Raider continues its flight test campaign at Edwards Air Force Base, California. (Photo Credit: Northrop Grumman)
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations